Company Data
BioAtla Inc.
Ticker
BCAB
Current Price
$0.1723 -6.86%
Market Cap
$10.9M
Price Target
Refer to Report
Volume
2.5M
52wk Range
$0.13 - $1.43
Overview
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.